EUVIMEDEUVIMED entdecken
Open Access

Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND

Judith S Hochman, Rebecca Anthopolos, Harmony R Reynolds, Sripal Bangalore, Yifan Xu, Sean M O'Brien, Stephanie Boumakis, Michelle Chang, Yves Rosenberg, Roxy Senior, Ann Banfield, Shaun G Goodman und 17 weitere

JAMA · 07.11.2026

DOI: 10.1001/jama.2026.20375 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JAMA, online erschienen am 07.11.2026. Verfasst von Judith S Hochman und 28 weiteren Autor:innen. Beteiligte Einrichtung: Cardiovascular Clinical Research Center, Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, N…. Die Arbeit nennt 27 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance It is unknown whether routine invasive management of chronic coronary disease improves long-term survival when added to guideline-directed medical therapy.

Objective

To compare the effects of initial invasive and conservative strategies on long-term mortality in patients with chronic coronary disease. Design, Setting, and Participants In this long-term follow-up study of the International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA), an international trial of patients with chronic coronary disease, moderate or severe ischemia, left ventricular ejection fraction of 35% or more, and no left main coronary artery disease, unacceptable angina, or recent acute coronary syndrome, participants were randomized at 320 sites in 37 countries beginning August 2012 and followed up through December 2025. Data were analyzed using the intention-to-treat principle.

Intervention

ISCHEMIA randomized patients to an initial invasive strategy of guideline-directed medical therapy plus coronary angiography and revascularization (when feasible) or an initial conservative strategy with guideline-directed medical therapy alone, with invasive management for failure of medical therapy. Main Outcomes and Measures All-cause, cardiovascular, and noncardiovascular mortality were analyzed using cumulative incidence estimates, Cox and Fine-Gray models, bayesian analysis, and restricted mean survival time.

Results

Among 5179 participants, median age was 64 (IQR, 58-70) years; 23% were female, 42% had diabetes, and median ejection fraction was 60% (IQR, 55%-65%). During 9-year median follow-up (range, 1 day to 13.4 years), 1071 deaths occurred (782 during extended follow-up): 672 cardiovascular, 359 noncardiovascular, and 40 unclassified. All-cause 11-year mortality was not significantly different between groups (25.8% invasive vs 26.9% conservative; estimated difference, −1.0 percentage point [95% CI, −4.2 to 2.1 percentage points]; adjusted hazard ratio [AHR], 0.97 [95% CI, 0.86-1.09]). By bayesian analysis, the posterior probability of more than 1 percentage-point survival benefit to invasive vs conservative was low (18%). Cardiovascular mortality at 11 years was 15.8% in the invasive group vs 17.1% in the conservative group (estimated difference, −1.4 percentage points [95% CI, −4.0 to 1.3 percentage points]; AHR, 0.88 [95% CI, 0.75-1.02]). Noncardiovascular mortality at 11 years was 9.1% in the invasive group vs 8.1% in the conservative group (estimated difference, 1.0 percentage point [95% CI, −0.9 to 2.9 percentage points]; AHR, 1.18 [95% CI, 0.96-1.45]). Eleven-year restricted mean survival was not significantly different (estimated difference, 14 days [95% CI, −41 to 70 days]). Conclusions and Relevance In this study, long-term all-cause mortality in patients with high-risk chronic coronary disease was not significantly different after routine invasive vs initial conservative management. Trial Registration ClinicalTrials.gov Identifier: NCT04894877

Autor:innen und Institutionen

  • Cardiovascular Clinical Research Center, Leon H. Charney Division of Cardiology, Department of Medicine, NYU Grossman School of Medicine, New York, New York.
  • Department of Population Health, NYU Grossman School of Medicine, New York, New York.
  • Duke Clinical Research Institute, Durham, North Carolina.
  • NYU Grossman School of Medicine, New York, New York.
  • National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland.
  • Northwick Park Hospital - Royal Brompton, London, United Kingdom.

Förderung

  • NHLBI NIH HHS

Zitieren

APA

Hochman, J. S., Anthopolos, R., Reynolds, H. R., Bangalore, S., Xu, Y., O'Brien, S. M., Boumakis, S., Chang, M., Rosenberg, Y., Senior, R., Banfield, A., Goodman, S. G., Lopes, R. D., Pracon, R., Lopez-Sendon, J., Steg, P. G., Maggioni, A. P., Newman, J. D., Berger, J. S., …, & ISCHEMIA-EXTEND Research Group (2026). Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND. JAMA. https://doi.org/10.1001/jama.2026.20375

Vancouver

Hochman JS, Anthopolos R, Reynolds HR, Bangalore S, Xu Y, O'Brien SM, et al. Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND. JAMA. 2026. doi:10.1001/jama.2026.20375

BibTeX
@article{Hochman2026,
  author = {Hochman, Judith S and Anthopolos, Rebecca and Reynolds, Harmony R and Bangalore, Sripal and Xu, Yifan and O'Brien, Sean M and Boumakis, Stephanie and Chang, Michelle and Rosenberg, Yves and Senior, Roxy and Banfield, Ann and Goodman, Shaun G and Lopes, Renato D and Pracon, Radoslaw and Lopez-Sendon, Jose and Steg, P Gabriel and Maggioni, Aldo Pietro and Newman, Jonathan D and Berger, Jeffrey S and Sidhu, Mandeep S and White, Harvey D and Troxel, Andrea B and Harrington, Robert A and Boden, William E and Stone, Gregg W and Mark, Daniel B and Spertus, John A and Maron, David J and ISCHEMIA-EXTEND Research Group, ISCHEMIA-EXTEND Research Group},
  title = {Long-Term Survival After Initial Invasive or Conservative Management of Stable Coronary Disease in ISCHEMIA-EXTEND},
  journal = {JAMA},
  year = {2026},
  doi = {10.1001/jama.2026.20375}
}
Kostenlos starten →